| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242058 | Respiratory Medicine | 2014 | 21 Pages |
Abstract
No clinically relevant trends were observed in the LOCS III assessment of lenticular shifts during treatment of COPD and asthma patients, although further study may be needed to confirm the findings presented here. In these trials, MF/F effects on lens opacity were not observed. (Clinicaltrials.gov numbers: NCT00383435, NCT00383721, and NCT00379288.)
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Jorge Maspero, Ivan Cherrez, Dennis E. Doherty, Donald P. Tashkin, Piotr Kuna, Wen-Ling Kuo, Davis Gates, Hendrik Nolte, Leo T. Jr.,